Cargando…
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males
Male hypogonadism is an increasingly prevalent clinical condition that affects patients’ quality of life and overall health. Obesity and metabolic syndrome can both cause and result from hypogonadism. Although testosterone remains the gold standard for hypogonadism management, its benefits are not a...
Autores principales: | Sinha, Deepankar K., Balasubramanian, Adithya, Tatem, Alexander J., Rivera-Mirabal, Jorge, Yu, Justin, Kovac, Jason, Pastuszak, Alexander W., Lipshultz, Larry I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/ https://www.ncbi.nlm.nih.gov/pubmed/32257855 http://dx.doi.org/10.21037/tau.2019.11.30 |
Ejemplares similares
-
Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
por: Sigalos, John T., et al.
Publicado: (2017) -
Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature
por: Tatem, Alexander J., et al.
Publicado: (2020) -
Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020) -
Binding Domain Characterization of Growth Hormone Secretagogue Receptor
por: Sun, Yuxiang, et al.
Publicado: (2022) -
Patient Attitudes Toward Testicular Prosthesis Placement After Orchiectomy
por: Srivatsav, Ashwin, et al.
Publicado: (2019)